NeoControl chair: Use 0029T whether Medicare covers it or not

Why This Topic Matters

Coverage for emerging technologies can vary widely by payer and geography, so practices need to understand when a reported service may be covered, denied, or shifted to patient responsibility. This article helps readers identify the coding and documentation context surrounding a specific urology therapy and its reimbursement challenges.

Article Sections

1. Coverage and billing context for NeoControl chair therapy

   Introduces the therapy, discusses payer variation, and frames the reimbursement issue for urology practices.

2. Coding and reporting guidance

   Explains the applicable CPT Category III reporting context and notes related coding alternatives mentioned in the article.

3. Documentation and local coverage policy

   Summarizes the general documentation expectations and the role of carrier coverage policies and session limits.

4. Practice experience and reimbursement impact

   Describes how different practices responded to coverage challenges and the broader billing implications.